Transgender Inc: The Billion-Dollar Industry on the Rise

The staggering rise of the transgender healthcare industry, known as "Transgender Inc," is projected to reach a whopping $7.5 billion by 2030.

The staggering rise of the transgender healthcare industry, known as "Transgender Inc," is projected to reach a whopping $7.5 billion by 2030. Chris Moritz states, "What I call transgender Inc. deserves to be highlighted in a very visible way."

He emphasizes the need to bring attention to the growing transgender healthcare market, especially concerning surgeries and hormone therapies. The market saw a surge from $2.94 billion in 2018 to an expected $7.5 billion by 2030.

---

---

However, Moritz notes, "There are no long-term studies that show the efficacy of taking these very powerful pharmaceuticals." The more graphic procedures, such as "vaginal plasti," are particularly concerning, where male-to-female patients undergo significant alterations.

Not surprisingly, "The Biden administration has kind of tacitly endorsed reconstructive surgery for minors." Yet, the number of transgender youth has doubled over five years, potentially facing "a lifetime of zero sexual function."

Furthermore, Moritz stresses, "There's absolutely zero scientific evidence that would suggest... a biological element to transgenderism that would result in what has become known as gender dysphoria."

Alarmingly, many pharmaceutical products used in gender transitions don't have FDA approval specifically for this purpose.

For instance, drugs like Lupron are under scrutiny for "advertising to children...off label."

This revealing deep dive, bolstered by Chris Moritz's insights, paints a concerning picture of the transgender healthcare industry, especially regarding the questionable ethics of performing such surgeries on minors.

Full Tucker on X interview: https://x.com/tuckercarlson/status/1709689853661913465

---

---